Food & Drug Administration | eHealth News | Page 56

The U.S. Food and Drug Administration has issued a warning that injectable skin-lightening products are potentially unsafe and ineffective.

FDA Issues Warning Regarding Injectable Skin Lighteners

HealthDay.com - Sep 3, 2015 0

Injectable products may contain unknown substances or contaminants

Varubi (rolapitant) has been approved by the U.S. Food and Drug Administration to prevent delayed phase chemotherapy-induced nausea and vomiting.

FDA Approves Varubi for Chemo-Induced Nausea, Vomiting

HealthDay.com - Sep 2, 2015 0

For prevention of the delayed phase of nausea, vomiting caused by chemotherapy

Repatha (evolocumab) has been approved by the U.S. Food and Drug Administration

FDA Approves Repatha for Certain Patients With High Cholesterol

HealthDay.com - Aug 28, 2015 0

Approved for patients unable to get LDL cholesterol under control with current treatment options

A proposal for identifying lower-cost generic biotech drugs has been released by the U.S. Food and Drug Administration.

FDA Issues Proposal on Lower-Cost, Generic Biotech Drugs

HealthDay.com - Aug 27, 2015 0

All biotech drugs to carry a four-letter code to distinguish brand name, generic versions

U.S. Food and Drug Administration approval of the drug Promacta (eltrombopag) has been expanded to include children 1 year and older with chronic immune thrombocytopenic purpura.

Promacta Approval Expanded for Children With Chronic ITP

HealthDay.com - Aug 24, 2015 0

Builds on recent approval for ages 6 years and up for chronic immune thrombocytopenic purpura

Addyi (flibanserin) has been approved by the U.S. Food and Drug Administration as the first drug to treat generalized hypoactive sexual desire disorder among premenopausal women. The drug is for women who do not have an underlying physical or psychological cause for the disorder

FDA Approves Libido Pill for Women

HealthDay.com - Aug 19, 2015 0

Addyi to treat generalized hypoactive sexual desire disorder among premenopausal women

New violations by the maker of medical scopes recently linked to deadly infections in patients have been discovered by the U.S. Food and Drug Administration.

FDA Reveals More Violations by Medical Scope Maker

HealthDay.com - Aug 18, 2015 0

Infections in patients who underwent procedures with Olympus scopes in 2012 went unreported

The age of 3D printing has come to the drug industry

FDA Approves First 3D Printed Prescription Medication

HealthDay.com - Aug 4, 2015 0

Epilepsy drug Spritam may be one of many custom-made medicines to come that will use the technology

The ReShape Integrated Dual Balloon System has been approved by the U.S. Food and Drug Administration to combat adult obesity. Inflated inside the stomach

FDA Approves Balloon Device to Treat Obesity

HealthDay.com - Jul 29, 2015 0

Inflated in stomach, it may create sense of fullness

Praluent (alirocumab) injection has been approved by the U.S. Food and Drug Administration for use in addition to diet and maximally tolerated statin therapy in adults with heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease

FDA Approves Praluent for Certain Cases of High Cholesterol

HealthDay.com - Jul 27, 2015 0

First in a new class of injectable cholesterol-lowering medications

1...555657...62 Page 56 of 62

Archives